Fundraising FoxMontreux Equity Partners — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Dignify Therapeutics is developing drug programs that induce on-demand defecation and urination to treat functional bowel and bladder disorders, including incontinence and retention associated with neurological conditions and aging.
BiotechDigital HealthMedical DevicesResearch Triangle Park, US
Edward C Burgard(Executive Officer, Director, Promoter)Karl Thor(Chief Scientific Officer)inBenny Ward(Executive Officer, Director, Promoter)inAnthony DiTonno(CEO)Ed Burgard(President)Jeff Welch(Chief Operating Officer)
Board seatHoward D. Palefsky· per SEC Form D · $3M raise · filed Sep 2026
Co-investorsEshelman Ventures, LLCRA Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.